Search results for "COPD"

Results 1 - 10 of about 84 for "COPD".

Corticosteroids have fallen out of favor for COPD care | ACP Internist

A single study has gone a long way toward changing clinical practices.

Get your COPD patients moving : ACP Internist

I'm at the American Thoracic Society annual meeting for the next couple of days, learning what's new in critical care, pulmonary and sleep m...

QD: News Every Day--Novel mechanism may improve steroid response of COPD : ACP Internist

Restoring corticosteroid sensitivity in patients with chronic obstructive pulmonary disease (COPD) may holds promise for effectively treatin...

COPD exacerbations and respiratory syncitial virus--maybe a huge problem? : ACP Internist

We're having a curtailed winter and early spring here in the inland Northwest, or so it seems. We could still get a snowstorm or 2, but the ...

‘Year of the Lung’ draws attention to COPD, asthma | ACP Internist

Chronic respiratory disease is projected to be the third most common cause of death by 2020, but it currently underestimated. This year's American Thoracic Society meeting focuses on issues to bring them to the attention of the rest of the medical

Catch up on new COPD guidelines | ACP Internist

Updated guidelines for chronic obstructive pulmonary disease revised the definition and staging of the condition, and an expert offers tips for optimal care.

New diabetes drug, LABA for COPD, skin antibiotic approved | ACP Internist

This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and

New drugs approved for type 2 diabetes and COPD | ACP Internist

This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.

New drugs approved for hypertension, lupus and COPD | ACP Internist

Recalls, warnings, and approvals.

New COPD treatment, warnings on insomnia and migraine drugs | ACP Internist

This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more.

Prev   1   2   3   4   5   6   7   8   9   Next